Results 251 to 260 of about 15,283 (290)

BIOPHARMACEUTICALS

2017
Biopharmaceuticals are primarily therapeutic proteins developed to perform specific functions by acting on the disease pathophysiology. Compared with low-molecular chemically synthesized drugs, production of biopharmaceuticals is much more complex and routes of administration and pharmacokinetics differ.
Gils, Ann, Bertolotto, Antonio, Mulleman, Denis, Bejan-Angoulvant, Theodora, Declerck, Paul   +4 more
openaire   +2 more sources

Biopharmaceutical benchmarks 2006

Nature Biotechnology, 2006
The rate of biopharmaceutical approvals has leveled off, but some milestones bode well for the future.
openaire   +2 more sources

Growing pains for biopharmaceuticals

Nature Biotechnology, 2001
Biopharmaceuticals have provided a swift means of swelling pharmaceutical company pipelines, but they may not be such a fast “fix” for the industry in the future.
openaire   +2 more sources

Biopharmaceutics Risk Assessment—Connecting Critical Bioavailability Attributes with In Vitro, In Vivo Properties and Physiologically Based Biopharmaceutics Modeling to Enable Generic Regulatory Submissions

AAPS Journal, 2023
Tausif Ahmed, Sivacharan Kollipara, Rajkumar Boddu   +2 more
exaly  

Biopharmaceuticals

2023
Serena Dasani, Rohan Palanki, Pallavi Menon, Sourav K. Bose   +3 more
openaire   +1 more source

Immunotoxicology of Biopharmaceutics

2010
H.G. Haggerty, K.D. Price, J.M. Shenton
openaire   +1 more source

Biopharmaceutical benchmarks

Nature Biotechnology, 2000
openaire   +2 more sources

iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System

Molecular Pharmaceutics, 2022
Per Bäckman, Ben Forbes, Jayne Hastedt
exaly  

An Introduction to Biopharmaceutics

2022
Hannah Batchelor
exaly  

pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery

Molecular Pharmaceutics, 2012
Li Di, Ayman El-Kattan, Charles J Rotter
exaly